Hemolytic disease of the newborn caused by anti-U: A case report

Main Article Content

Renata Esteves Almeida
Sandro Artur Fierz
Flavia Miranda Constantino-Bandeira
Patricia Olga Souza-Sergio
Cristiane Sá Ferreira Facio
Alexandre Gomes Vizzoni*

Abstract

Maternal red blood cell alloimmunization is an important cause of morbidity and mortality in the antepartum and neonatal periods. Typically, the serological diagnosis of Hemolytic Disease of the Fetus and Newborn (HDFN) includes a positive direct antiglobulin test on the infant’s red blood cells and the presence of an IgG red cell alloantibody in both maternal and cord sera.

Downloads

Download data is not yet available.

Article Details

Almeida, R. E., Fierz, S. A., Constantino-Bandeira, F. M., Souza-Sergio, P. O., Facio, C. S. F., & Gomes Vizzoni, A. (2020). Hemolytic disease of the newborn caused by anti-U: A case report. Global Journal of Medical and Clinical Case Reports, 7(1), 010–012. https://doi.org/10.17352/2455-5282.000080
Case Reports

Copyright (c) 2020 Almeida RE, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Xie X, Fu Q, Bao Z, Zhang Y, Zhou D (2020) Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis. PLoS One 15: e0230073. Link: https://bit.ly/2yddO5c

Koelewijn JM, Slootweg YM, Folman C, van Kamp IL, Oepkes D, et al. (2020) Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies. Transfusion 60: 391-399. Link: https://bit.ly/2ygOEmd

Moinuddin I, Fletcher C, Millward P (2019) Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan. J Blood Med 10: 283-289. Link: https://bit.ly/2XAVzRB

Win N, Almusawy M, Fitzgerald L, Hannah G, Bullock T (2019) Prevention of hemolytic transfusion reactions with intravenous immunoglobulin prophylaxis in U– patients with anti-U. Transfusion 59: 1916-1920. Link: https://bit.ly/3abBGmI

Adam S, Lombaard H (2016) Autologous intrauterine transfusion in a case of anti-U. Transfusion 56: 3029-3032. Link: https://bit.ly/34Bcjts

Moosavi M, Ma Y, Baez J, Jeffreys R, Ward DC, et al. (2020) Resolving Blocked Antigen Phenomenon in Hemolytic Disease of the Fetus and Newborn Due to Anti-K. Transfus Med Rev pii: S0887-7963(20)30013-4. Link: https://bit.ly/2V9wjjJ

Santos FLS, Cuter TB, Rodrigues ES, Bettarello ÊC, Ubiali EMA, et al. (2019) Molecular analysis of the rare S–s– red blood cell phenotype in blood donors and patients in south-east Brazil. Vox Sang 114: 262-267. Link: https://bit.ly/2K61p5N